Radnet Inc (RDNT) 7.23 $RDNT Davita's Expenses
Post# of 273242
Posted On: 09/19/2016 3:20:33 PM
Radnet Inc (RDNT) 7.23 $RDNT
Davita's Expenses Continue to Rise: Time to Dump the Stock?
Zacks Equity Research - Zacks Investment Research - Mon Sep 19, 9:23AM CDT
On Sep 19, we issued an updated research report on DaVita Inc. (DVA).
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), DVA: 63.77 (-0.67), RDNT: 7.23 (+0.24)
This Week's Hidden Gems: (RDNT) (HLTH)
Tracey Ryniec - Zacks Investment Research - Thu Sep 15, 3:40PM CDT
Tracey Ryniec uncovers opportunities in 2 niche healthcare companies.
HLTH: 3.45 (+0.13), RDNT: 7.23 (+0.24)
IMS Health (IMS) Prices Upsized Offering of Senior Notes
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 10:14AM CDT
IMS Health Holdings, Inc. (IMS) announced the pricing of a senior notes offering worth $1.75 billion.
IMS: 29.73 (+0.13), USPH: 64.13 (+0.19), Q: 77.46 (+0.15), RDNT: 7.23 (+0.24)
Becton, Dickinson (BDX) Gets USFDA Clearance for BD MAX
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:29AM CDT
Becton, Dickinson and Company (BDX) recently announced that it got the clearance for its proprietary BD MAX CT/GC/TV assay from the U.S. Food and Drug Administration.
BDX: 176.03 (+0.83), USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24)
RadNet Up 18.6% Since SmarTrend Uptrend Call (RDNT)
Comtex SmarTrend(R) - Thu Sep 15, 1:06AM CDT
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on July 11th, 2016 at $5.67. In approximately 2 months, RadNet has returned 18.62% as of today's recent price of $6.72.
RDNT: 7.23 (+0.24)
BioScrip Buys Home Solutions, Strengthens Infusion Business
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 9:06AM CDT
BioScrip, Inc. (BIOS) has completed the acquisition of home infusion and home nursing products and services business Home Solutions.
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), BIOS: 2.92 (+0.17)
AmSurg Expands in Anesthesiology, Enters South California
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 6:22AM CDT
Sheridan ??? the Physician Services Division of AmSurg Corp. (AMSG) ??? acquired Ambulatory Anesthesia Associates, Inc. and Genesis Anesthesia Services, Inc.
AMSG: 65.40 (-0.06), USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24)
eRAD Releases RADAR Nudge Messaging Tool
GlobeNewswire - Thu Sep 08, 10:38AM CDT
eRAD announced that it has added a new product to its comprehensive suite of imaging workflow solutions. Released today, RADAR Nudge is a bi-directional, secure collaborative messaging tool for communicating patient information among remote healthcare providers.
RDNT: 7.23 (+0.24)
24.4% Return Seen to Date on SmarTrend RadNet Call (RDNT)
Comtex SmarTrend(R) - Wed Sep 07, 2:13PM CDT
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on July 11th, 2016 at $5.67. In approximately 2 months, RadNet has returned 24.45% as of today's recent price of $7.05.
RDNT: 7.23 (+0.24)
BioScrip's Deal with Home Solutions Revised, To Close Soon
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 5:07AM CDT
BioScrip (BIOS) recently amended the earlier terms of the agreement to acquire the Home Solutions business of HS Infusion Holdings, Inc.
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), BIOS: 2.92 (+0.17)
Quest Diagnostics' Sonora Quest Opens PSCs at Safeway
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
Sonora Quest Laboratories of Quest Diagnostics (DGX), has recently opened six new Patient Service Centers (PSCs) at Safeway stores in Arizona.
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), DGX: 83.57 (+0.32)
Moving Average Crossover Alert: RadNet (RDNT)
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:41AM CDT
RadNet, Inc. (RDNT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
RDNT: 7.23 (+0.24)
Quest Diagnostics: Strategic Initiatives & Tie-ups to Add Value
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:43AM CDT
On Aug 23, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), DGX: 83.57 (+0.32)
DaVita (DVA) Continues to Underperform: Time to Offload it?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:53AM CDT
On Aug 17, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA)
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), DVA: 63.77 (-0.67), RDNT: 7.23 (+0.24)
BioScrip (BIOS) Posts Strong Q2, Strategic Plans on Track
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 1:07PM CDT
On Aug 12, 2016, we issued an updated research report on BioScrip, Inc. (BIOS).
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), BIOS: 2.92 (+0.17)
RadNet Reports Second Quarter Financial Results and Reaffirms Previously Announced 2016 Guidance Levels
GlobeNewswire - Tue Aug 09, 5:00AM CDT
-- Total Net Revenue, modified for working capital adjustments related to New York acquisitions, ("Adjusted Revenue"
, increased 10.0% to $224.6 million in the second quarter of 2016 from $204.3 million in the second quarter of 2015
RDNT: 7.23 (+0.24)
eRAD Announces 11 New Customers for the 2nd Quarter of 2016 and YTD Implementations Not Previously Announced
GlobeNewswire - Mon Aug 01, 9:28AM CDT
eRAD, a division of RadNet, Inc. and an industry leader in Web-based RIS, PACS, and Teleradiology workflow solutions, announced today the company has taken several direct orders from new customers during the second quarter of 2016. All sales not previously announced are also noted. eRAD's products and services are available from a number of geographically dispersed valued-added resellers, brokers, and/or distributors in the United States and abroad, as well as direct from the manufacturer.
RDNT: 7.23 (+0.24)
RadNet, Inc. Announces Date of its Second Quarter 2016 Financial Results Conference Call
GlobeNewswire - Mon Aug 01, 5:00AM CDT
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2016 financial results on Tuesday, August 9, 2016 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
RDNT: 7.23 (+0.24)
RadNet, Inc. to Present at the Jefferies 2016 Healthcare Conference on June 10, 2016
GlobeNewswire - Thu Jun 09, 11:23AM CDT
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Steve Forthuber, Executive Vice President and Chief Operating Officer - East Coast, will be presenting at the Jefferies 2016 Global Healthcare Conference in New York, NY on Friday, June 10, 2016 at 1:00 p.m. Eastern Time.
RDNT: 7.23 (+0.24)
RadNet Announces a Proposed Refinancing of its $444.8 Million Senior Secured First Lien Term Loans and $101.25 Million Senior Secured Revolving Credit Facility
GlobeNewswire - Thu Jun 02, 5:00AM CDT
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 309 owned and/or operated outpatient imaging centers, today announced a proposed refinancing of its $444.8 million senior secured first lien term loans and $101.25 million senior secured revolving credit facility with a proposed seven-year $485 million senior secured first lien term loan facility and a five-year $100 million senior secured first lien revolving credit facility. In addition to repaying the existing $444.8 million senior secured first lien term loan, the proceeds are expected to repay any outstanding balance on the existing senior secured revolving credit facility ($16.3 million balance at March 31, 2016) and a portion of the Company's senior secured second lien term loan ($180 million balance at March 31, 2016) and fund fees and expenses associated with the refinancing transaction.
RDNT: 7.23 (+0.24)
Davita's Expenses Continue to Rise: Time to Dump the Stock?
Zacks Equity Research - Zacks Investment Research - Mon Sep 19, 9:23AM CDT
On Sep 19, we issued an updated research report on DaVita Inc. (DVA).
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), DVA: 63.77 (-0.67), RDNT: 7.23 (+0.24)
This Week's Hidden Gems: (RDNT) (HLTH)
Tracey Ryniec - Zacks Investment Research - Thu Sep 15, 3:40PM CDT
Tracey Ryniec uncovers opportunities in 2 niche healthcare companies.
HLTH: 3.45 (+0.13), RDNT: 7.23 (+0.24)
IMS Health (IMS) Prices Upsized Offering of Senior Notes
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 10:14AM CDT
IMS Health Holdings, Inc. (IMS) announced the pricing of a senior notes offering worth $1.75 billion.
IMS: 29.73 (+0.13), USPH: 64.13 (+0.19), Q: 77.46 (+0.15), RDNT: 7.23 (+0.24)
Becton, Dickinson (BDX) Gets USFDA Clearance for BD MAX
Zacks Equity Research - Zacks Investment Research - Thu Sep 15, 9:29AM CDT
Becton, Dickinson and Company (BDX) recently announced that it got the clearance for its proprietary BD MAX CT/GC/TV assay from the U.S. Food and Drug Administration.
BDX: 176.03 (+0.83), USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24)
RadNet Up 18.6% Since SmarTrend Uptrend Call (RDNT)
Comtex SmarTrend(R) - Thu Sep 15, 1:06AM CDT
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on July 11th, 2016 at $5.67. In approximately 2 months, RadNet has returned 18.62% as of today's recent price of $6.72.
RDNT: 7.23 (+0.24)
BioScrip Buys Home Solutions, Strengthens Infusion Business
Zacks Equity Research - Zacks Investment Research - Wed Sep 14, 9:06AM CDT
BioScrip, Inc. (BIOS) has completed the acquisition of home infusion and home nursing products and services business Home Solutions.
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), BIOS: 2.92 (+0.17)
AmSurg Expands in Anesthesiology, Enters South California
Zacks Equity Research - Zacks Investment Research - Fri Sep 09, 6:22AM CDT
Sheridan ??? the Physician Services Division of AmSurg Corp. (AMSG) ??? acquired Ambulatory Anesthesia Associates, Inc. and Genesis Anesthesia Services, Inc.
AMSG: 65.40 (-0.06), USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24)
eRAD Releases RADAR Nudge Messaging Tool
GlobeNewswire - Thu Sep 08, 10:38AM CDT
eRAD announced that it has added a new product to its comprehensive suite of imaging workflow solutions. Released today, RADAR Nudge is a bi-directional, secure collaborative messaging tool for communicating patient information among remote healthcare providers.
RDNT: 7.23 (+0.24)
24.4% Return Seen to Date on SmarTrend RadNet Call (RDNT)
Comtex SmarTrend(R) - Wed Sep 07, 2:13PM CDT
SmarTrend identified an Uptrend for RadNet (NASDAQ:RDNT) on July 11th, 2016 at $5.67. In approximately 2 months, RadNet has returned 24.45% as of today's recent price of $7.05.
RDNT: 7.23 (+0.24)
BioScrip's Deal with Home Solutions Revised, To Close Soon
Zacks Equity Research - Zacks Investment Research - Tue Sep 06, 5:07AM CDT
BioScrip (BIOS) recently amended the earlier terms of the agreement to acquire the Home Solutions business of HS Infusion Holdings, Inc.
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), BIOS: 2.92 (+0.17)
Quest Diagnostics' Sonora Quest Opens PSCs at Safeway
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 8:12AM CDT
Sonora Quest Laboratories of Quest Diagnostics (DGX), has recently opened six new Patient Service Centers (PSCs) at Safeway stores in Arizona.
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), DGX: 83.57 (+0.32)
Moving Average Crossover Alert: RadNet (RDNT)
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:41AM CDT
RadNet, Inc. (RDNT) is looking like an interesting pick from a technical perspective, as the company is seeing favorable trends on the moving average crossover front
RDNT: 7.23 (+0.24)
Quest Diagnostics: Strategic Initiatives & Tie-ups to Add Value
Zacks Equity Research - Zacks Investment Research - Tue Aug 23, 9:43AM CDT
On Aug 23, 2016, we issued an updated research report on Quest Diagnostics, Inc. (DGX).
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), DGX: 83.57 (+0.32)
DaVita (DVA) Continues to Underperform: Time to Offload it?
Zacks Equity Research - Zacks Investment Research - Wed Aug 17, 8:53AM CDT
On Aug 17, 2016, we issued an updated research report on DaVita HealthCare Partners Inc. (DVA)
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), DVA: 63.77 (-0.67), RDNT: 7.23 (+0.24)
BioScrip (BIOS) Posts Strong Q2, Strategic Plans on Track
Zacks Equity Research - Zacks Investment Research - Tue Aug 16, 1:07PM CDT
On Aug 12, 2016, we issued an updated research report on BioScrip, Inc. (BIOS).
USPH: 64.13 (+0.19), AFAM: 35.38 (-0.42), RDNT: 7.23 (+0.24), BIOS: 2.92 (+0.17)
RadNet Reports Second Quarter Financial Results and Reaffirms Previously Announced 2016 Guidance Levels
GlobeNewswire - Tue Aug 09, 5:00AM CDT
-- Total Net Revenue, modified for working capital adjustments related to New York acquisitions, ("Adjusted Revenue"
, increased 10.0% to $224.6 million in the second quarter of 2016 from $204.3 million in the second quarter of 2015 RDNT: 7.23 (+0.24)
eRAD Announces 11 New Customers for the 2nd Quarter of 2016 and YTD Implementations Not Previously Announced
GlobeNewswire - Mon Aug 01, 9:28AM CDT
eRAD, a division of RadNet, Inc. and an industry leader in Web-based RIS, PACS, and Teleradiology workflow solutions, announced today the company has taken several direct orders from new customers during the second quarter of 2016. All sales not previously announced are also noted. eRAD's products and services are available from a number of geographically dispersed valued-added resellers, brokers, and/or distributors in the United States and abroad, as well as direct from the manufacturer.
RDNT: 7.23 (+0.24)
RadNet, Inc. Announces Date of its Second Quarter 2016 Financial Results Conference Call
GlobeNewswire - Mon Aug 01, 5:00AM CDT
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of owned and operated outpatient imaging centers, announced today that it will host a conference call to discuss its second quarter 2016 financial results on Tuesday, August 9, 2016 at 7:30 a.m. Pacific Time (10:30 a.m. Eastern Time).
RDNT: 7.23 (+0.24)
RadNet, Inc. to Present at the Jefferies 2016 Healthcare Conference on June 10, 2016
GlobeNewswire - Thu Jun 09, 11:23AM CDT
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective diagnostic imaging services through a network of fully-owned and operated outpatient imaging centers, today announced that Steve Forthuber, Executive Vice President and Chief Operating Officer - East Coast, will be presenting at the Jefferies 2016 Global Healthcare Conference in New York, NY on Friday, June 10, 2016 at 1:00 p.m. Eastern Time.
RDNT: 7.23 (+0.24)
RadNet Announces a Proposed Refinancing of its $444.8 Million Senior Secured First Lien Term Loans and $101.25 Million Senior Secured Revolving Credit Facility
GlobeNewswire - Thu Jun 02, 5:00AM CDT
RadNet, Inc. (NASDAQ:RDNT), a national leader in providing high-quality, cost-effective, fixed-site outpatient diagnostic imaging services through a network of 309 owned and/or operated outpatient imaging centers, today announced a proposed refinancing of its $444.8 million senior secured first lien term loans and $101.25 million senior secured revolving credit facility with a proposed seven-year $485 million senior secured first lien term loan facility and a five-year $100 million senior secured first lien revolving credit facility. In addition to repaying the existing $444.8 million senior secured first lien term loan, the proceeds are expected to repay any outstanding balance on the existing senior secured revolving credit facility ($16.3 million balance at March 31, 2016) and a portion of the Company's senior secured second lien term loan ($180 million balance at March 31, 2016) and fund fees and expenses associated with the refinancing transaction.
RDNT: 7.23 (+0.24)
(0)
(0)Scroll down for more posts ▼